Evaluating the American Society of Hematology quality measure on timeliness of analgesics for sickle cell disease pain crisis.

Gwarzo I, Dega HC, Tanabe P, Miller R, Brousseau DC

Open source

DOI
10.1182/bloodadvances.2025017709
Published
2026 Feb 24
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025017709,
  title = {Evaluating the American Society of Hematology quality measure on timeliness of analgesics for sickle cell disease pain crisis.},
  author = {Gwarzo I and Dega HC and Tanabe P and Miller R and Brousseau DC},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2025017709},
  url = {https://doi.org/10.1182/bloodadvances.2025017709}
}

RIS

TY  - JOUR
TI  - Evaluating the American Society of Hematology quality measure on timeliness of analgesics for sickle cell disease pain crisis.
AU  - Gwarzo I
AU  - Dega HC
AU  - Tanabe P
AU  - Miller R
AU  - Brousseau DC
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2025017709
UR  - https://doi.org/10.1182/bloodadvances.2025017709
ER  - 

APA

I, G., HC, D., P, T., R, M., & DC, B. (2026). Evaluating the American Society of Hematology quality measure on timeliness of analgesics for sickle cell disease pain crisis.. Blood advances. https://doi.org/10.1182/bloodadvances.2025017709

Source records